Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Co-amilozide (Amiloride hydrochloride/hydrochlorothiazide)
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Co-amilozide 5mg/50mg tablets
0202040C0AAAAAA
|
Co-amilozide | Co-amilozide (Amiloride hydrochloride/hydrochlorothiazide) | Cardiovascular System | 10,060 |
|
Co-amilozide 2.5mg/25mg tablets
0202040C0AAABAB
|
Co-amilozide | Co-amilozide (Amiloride hydrochloride/hydrochlorothiazide) | Cardiovascular System | 8,275 |
|
Moduretic 5mg/50mg tablets
0202040C0BDAAAA
|
Moduretic | Co-amilozide (Amiloride hydrochloride/hydrochlorothiazide) | Cardiovascular System | 600 |
|
Amil-Co 5mg/50mg tablets
0202040C0BBAAAA
|
Amil-Co | Co-amilozide (Amiloride hydrochloride/hydrochlorothiazide) | Cardiovascular System | No data available |
|
Amilmaxco 5mg/50mg tablets
0202040C0BGAAAA
|
Amilmaxco | Co-amilozide (Amiloride hydrochloride/hydrochlorothiazide) | Cardiovascular System | No data available |
|
Co-amilozide 5mg/50mg/5ml oral solution
0202040C0AAACAC
|
Co-amilozide | Co-amilozide (Amiloride hydrochloride/hydrochlorothiazide) | Cardiovascular System | No data available |
|
Moduret 25 tablets
0202040C0BIAAAB
|
Moduret 25 | Co-amilozide (Amiloride hydrochloride/hydrochlorothiazide) | Cardiovascular System | No data available |
|
Synuretic 25 tablets
0202040C0BFABAB
|
Synuretic | Co-amilozide (Amiloride hydrochloride/hydrochlorothiazide) | Cardiovascular System | No data available |
|
Synuretic 50 tablets
0202040C0BFAAAA
|
Synuretic | Co-amilozide (Amiloride hydrochloride/hydrochlorothiazide) | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.